ID   HCCLM3-GFP-LC3
AC   CVCL_WJ13
DR   cancercelllines; CVCL_WJ13
DR   CCRID; 4201PAT-CCTCC00405
DR   Wikidata; Q93984342
RX   Patent=CN102115730A;
RX   PubMed=24058558;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2010102.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; 14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: HGNC; 6838; MAP1LC3A.
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6832 ! HCCLM3
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 8
//
RX   Patent=CN102115730A;
RA   Fan J., Shi Y.-H., Peng Y.-F., Ding Z.-B.;
RT   "High metastatic potential hepatoma cell line capable of steady
RT   autophagy indication, and establishment method and application method
RT   thereof.";
RL   Patent number CN102115730A, 06-Jul-2011.
//
RX   PubMed=24058558; DOI=10.1371/journal.pone.0074407;
RA   Peng Y.-F., Shi Y.-H., Shen Y.-H., Ding Z.-B., Ke A.-W., Zhou J.,
RA   Qiu S.-J., Fan J.;
RT   "Promoting colonization in metastatic HCC cells by modulation of
RT   autophagy.";
RL   PLoS ONE 8:E74407-E74407(2013).
//